» Articles » PMID: 34664389

COVID19 Disease Map, a Computational Knowledge Repository of Virus-host Interaction Mechanisms

Overview
Journal Mol Syst Biol
Specialty Molecular Biology
Date 2021 Oct 19
PMID 34664389
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective.

Citing Articles

Leveraging public AI tools to explore systems biology resources in mathematical modeling.

Kannan M, Bridgewater G, Zhang M, Blinov M NPJ Syst Biol Appl. 2025; 11(1):15.

PMID: 39910106 PMC: 11799200. DOI: 10.1038/s41540-025-00496-z.


Petagraph: A large-scale unifying knowledge graph framework for integrating biomolecular and biomedical data.

Stear B, Mohseni Ahooyi T, Simmons J, Kollar C, Hartman L, Beigel K Sci Data. 2024; 11(1):1338.

PMID: 39695169 PMC: 11655564. DOI: 10.1038/s41597-024-04070-w.


Comprehensive molecular interaction map of TGFβ induced epithelial to mesenchymal transition in breast cancer.

Gottumukkala S, Ganesan T, Palanisamy A NPJ Syst Biol Appl. 2024; 10(1):53.

PMID: 38760412 PMC: 11101644. DOI: 10.1038/s41540-024-00378-w.


Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.

Niarakis A, Ostaszewski M, Mazein A, Kuperstein I, Kutmon M, Gillespie M Front Immunol. 2024; 14:1282859.

PMID: 38414974 PMC: 10897000. DOI: 10.3389/fimmu.2023.1282859.


Role of the Neanderthal Genome in Genetic Susceptibility to COVID-19: 3p21.31 Locus in the Spotlight.

Yaghmouri M, Izadi P Biochem Genet. 2024; 62(6):4239-4263.

PMID: 38345759 DOI: 10.1007/s10528-024-10669-w.


References
1.
Balaur I, Roy L, Mazein A, Karaca S, Dogrusoz U, Barillot E . cd2sbgnml: bidirectional conversion between CellDesigner and SBGN formats. Bioinformatics. 2020; 36(8):2620-2622. DOI: 10.1093/bioinformatics/btz969. View

2.
Rao M, Dodoo E, Zumla A, Maeurer M . Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies. Front Microbiol. 2019; 10:962. PMC: 6514247. DOI: 10.3389/fmicb.2019.00962. View

3.
Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H . Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020; 130(5):2620-2629. PMC: 7190990. DOI: 10.1172/JCI137244. View

4.
Ghosh S, Dellibovi-Ragheb T, Kerviel A, Pak E, Qiu Q, Fisher M . β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell. 2020; 183(6):1520-1535.e14. PMC: 7590812. DOI: 10.1016/j.cell.2020.10.039. View

5.
Hui K, Cheung M, Perera R, Ng K, Bui C, Ho J . Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020; 8(7):687-695. PMC: 7252187. DOI: 10.1016/S2213-2600(20)30193-4. View